Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,832 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity.
Çakır I, Hadley CK, Pan PL, Bagchi RA, Ghamari-Langroudi M, Porter DT, Wang Q, Litt MJ, Jana S, Hagen S, Lee P, White A, Lin JD, McKinsey TA, Cone RD. Çakır I, et al. Among authors: white a. Nat Metab. 2022 Jan;4(1):44-59. doi: 10.1038/s42255-021-00515-3. Epub 2022 Jan 17. Nat Metab. 2022. PMID: 35039672 Free PMC article.
Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator.
Hong TT, Driscoll EM, White AJ, Sherigill A, Giboulot TA, Lucchesi BR. Hong TT, et al. Among authors: white aj. J Pharmacol Exp Ther. 2003 Aug;306(2):616-23. doi: 10.1124/jpet.103.052886. Epub 2003 May 6. J Pharmacol Exp Ther. 2003. PMID: 12734394
Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis.
Lauver DA, Booth EA, White AJ, Poradosu E, Lucchesi BR. Lauver DA, et al. Among authors: white aj. J Pharmacol Exp Ther. 2005 Feb;312(2):794-800. doi: 10.1124/jpet.104.075283. Epub 2004 Sep 13. J Pharmacol Exp Ther. 2005. PMID: 15365091
The present study assessed the cardioprotective effects of sulodexide (KRX-101), a mixture of GAGs composed of 80% low-molecular mass heparin and 20% dermatan sulfate. ...Infarct size, as a percentage of the area at risk, was calculated for both groups. ...
The present study assessed the cardioprotective effects of sulodexide (KRX-101), a mixture of GAGs composed of 80% low-molecular mass …
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
Murphy AD, Porter C, White A, Irving A, Adams R, Ray R, Casbard A, Mahmood RD, Karanth S, Zhou C, Pugh J, Wheeler C, Roberts V, Arnetoli G, Salih Z, Hasan J, Mitchell C, Morgan RD, Clamp AR, Jayson GC. Murphy AD, et al. Among authors: white a. Int J Gynecol Cancer. 2024 May 9:ijgc-2024-005455. doi: 10.1136/ijgc-2024-005455. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38724236
Updating the Data: The Resource Consumption of Modern-Day Hemodialysis Systems.
Barraclough KA, Moller S, Blair S, Knight R, Agar JW, McAlister S, White A, Sypek M. Barraclough KA, et al. Among authors: white a. Kidney Int Rep. 2024 Feb 12;9(5):1521-1524. doi: 10.1016/j.ekir.2024.02.010. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707837 Free PMC article. No abstract available.
6,832 results